CHOP Cancer Researchers Win 2021 AACR Team Science Award
Published on in CHOP News
The award was presented to the St. Baldrick’s Foundation-Stand Up 2 Cancer Pediatric Cancer Dream Team, co-led by CHOP, at the annual AACR conference.
Cancer Center News and Updates
1 - 10 of 259
The EVAN Foundation Pledges to Continue its Support of the Evan Lindberg Neuroblastoma Research Scholars Program at CHOP
Published on in CHOP News
Established in 2015, the Evan Lindberg Neuroblastoma Research Scholars Program supports exceptional early-career scientists at CHOP who are dedicated to finding a cure for neuroblastoma.
CHOP Researchers Awarded Crazy 8 Grant from Alex’s Lemonade Stand Foundation
Published on in CHOP News
CHOP researchers will receive funds to discover a new drug that targets MYCN, a transcription factor involved in some pediatric cancers.
Study Shows Benefit of Blinatumomab for High-Risk Relapsed B-ALL
Published on in CHOP News
A new study involving CHOP researchers show blinatumomab is less toxic and as good or better than chemotherapy for high-risk relapsed B-ALL.
Shannon Maude, MD, Discusses Unique Challenges Facing CAR-T Cell Therapy in Healio Article
Published on in CHOP News
Dr. Shannon Maude, an attending physician in the Cancer Center at CHOP, provided expert insight on the unique challenges facing CAR T-cell therapy for pediatric indications in an article published in Healio’s February issue of Cell Therapy Next.
Frank Balis, MD, Chairs National Panel that Released First-ever Treatment Guidelines for Wilms Tumor
Published on in CHOP News
The National Comprehensive Cancer Network (NCCN) recently published its first-ever treatment guidelines for Wilms' tumor.
Case Study: Concurrent Bilateral Partial Nephrectomies for Wilms Tumors
Published on in CHOP News
A multispecialty collaboration of oncology, urology, and radiology saved the patient from undergoing two rounds of anesthesia.
CHOP Researchers Find NTRK Fusions More Common than Expected in Pediatric Tumors
Published on in CHOP News
CHOP researchers have found that NTRK fusions are more common than expected in pediatric tumors, which could lead to better screening and treatment.
FDA Approves Drug for Rare Form of Pediatric Cancer
Published on in CHOP News, Cancer Connections
The FDA has approved a treatment that targets ALK mutations in relapsed, refractory ALK-positive anaplastic large cell lymphoma.
Study Demonstrates Efficacy of New Treatment for Neurofibromatosis Type 1-Related Tumors
Published on in CHOP News
A Phase 2 clinical trial involving CHOP and the Neurofibromatosis Clinical Trials Consortium showed cabozantinib reduced tumor volume and pain.